The Effect of Matricaria Chamomile and Rhus Coriaria on some Uterine Fibroma Symptoms in Wome

Phase 3

Recruiting

• Conditions: terine Fibroma.

• Registration Number: IRCT20200113046115N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 April 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 183

Inclusion Criteria

Women with Fibroid Disease Confirmed by a Gynecologist
Women who are willing to Cooperate and Submit Their Written Consent
Not taking any Hormonal Medication
The patient is not involved in any other diseases, including thyroid disease, endometriosis, adenomyosis and malignancies, etc. (Based on patient records)
Don't be pregnant
Don't be lactating
Not Allergic to Chamomile and Sumac and Mefenamic Acid
No History of Gastrointestinal, liver, Brain and Kidney Disease and Coagulation disorders
Body Mass Index 19-29
Age range 20-49 years
No history of prolonged constipation

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Moderate to severe pain. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Pain measurement by using visual analogue scale.;Bleeding includes menorrhagia and menometrorrhagia. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Using a pictorial blood assessment chart, patient with the bleeding score higher than 100 will study The pre-study and post-study scores will be compared.;Frequent urination more than 7 times a day. Timepoint: Before intervention and 2 months after intervention. Method of measurement: urination will be entered into the study more than 7 times a day and the number of urination before and after the intervention will be questioned and recorded and compared by the patient.